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Background: The tuberculin skin test (TST) is the recommended method for screening for Mycobacterium tuberculosis
infection in many countries. We used this technique to assess bacillus Calmette-Guérin (BCG) status and to estimate the
current prevalence and annual rate of latent tuberculosis infection in schoolchildren in the Central African Republic.
Methods: Two tuberculin units of 0.1 ml purified protein derivative TR23 were injected intradermally into the left
forearm of 2710 children attending school in Bangui and Ombella M’Poko. The induration size was interpreted at
cut-off points of ≥5 mm, ≥10 mm and ≥15 mm. The annual infection rate was estimated as the average number
of infections in the study sample each year between birth and the time of the survey.
Results: Overall, there was no reaction to the TST (no induration) in 71.7 % (95 CI, 68.3–75.3 %) of BCG-vaccinated
children and 82.9 % (95 CI, 74.1–91.4 %) of non-vaccinated children. The proportions of children who gave a TST
reaction above ≥10 mm and ≥15 mm cut-off was 18.4 % (95 % CI, 16.8–20.1 %) and 8.9 % (95 % CI, 7.8–10.0 %),
respectively. The proportions of TST reaction above these cut-offs were 19.6 % (95 % CI, 17.4–21.9 %) and 8.1 %
(95 % CI, 6.7–9.6 %), respectively. The annual infection rate was 0.8 % at the cut-off point of ≥15 mm.
Conclusion: This study provides updated data on rates of tuberculosis infection in the Central African Republic. It
is remarkable that most of the children had negative tuberculin reactivity. More studies are required to understand the
factors that determine the low tuberculin reactivity in this population.
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In 2010, WHO reported that one third of the world’s
population had latent tuberculosis (TB) infection, with
9.4 million new overt cases annually [1]. Children are
important targets for the prevention of tuberculosis (TB)
infection because they are at greatest risk for activation
of their infections [2]. The tuberculin skin test (TST) is
widely used in screening for latent M. tuberculosis infection
and for determining induced hypersensitivity pre- and post-
vaccination in schoolchildren [3–5].
In 2010 in the Central African Republic, mortality
from TB was estimated at 50 per 100,000 population
and the incidence at 367 per 100, 000 [6]. A national TB* Correspondence: amanirak@yahoo.fr
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article, unless otherwise stated.control programme was established in 1995 with the
objective of reducing the incidence and prevalence of
TB by 50 % before 2015. The directly observed therapy
short course (DOTS) strategy was introduced in 2005;
coverage reached 76 % in 2009, and 4305 new TB cases
were notified [7]. A paediatric survey conducted in 2011
in Bangui showed a rate of positive sputum smear pul-
monary TB of 23.5 % among 425 clinically suspected
cases (G. Bobossi-Serengbe, unpublished data).
All neonates are vaccinated according to the BCG
immunization policy at birth or within a few days of birth,
as suggested by WHO [8]. BCG vaccination coverage in
children was estimated at 72.4 % in 2010 [9]. The extent
of TB infection in the Central African Republic has never
been surveyed with the TST since establishment of the
national programme, and the only data available on tuber-
culin reactivity in the country were reported in a survey
conducted in 1988 in Bangui [10], which showed aed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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nual risk of 1.1 %. These figures rank the country among
those with a low prevalence. These data are, however,
old and refer only to Bangui. The study reported here
provides recent data on TST outcomes in both Bangui,
the capital, and also in the neighbouring rural area of
Ombella M’Poko.Fig. 1 Location of study area: health regions 1 and 7. This map was create
African Republic shape file available at http://wwwn.cdc.gov/epiinfo/html/sMethods
Survey area and population
As part of a policy to decentralize the health system, the
Central African Republic was divided into seven health
regions (Fig. 1). This survey was conducted in health re-
gions one (Ombella M’Poko, a rural district) and seven
(Bangui city, the capital of the Central African Republic)d by the authors using the QGIS 2.2.0 software, from the Central
hapefiles.htm
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tants, respectively (general population census, 2005). The
TB rate is 134 per 100,000 population in Ombella M’Poko
and 284 per 100,000 population in Bangui. The study popu-
lation comprised primary schoolchildren aged 6–12 years.
Ethics statement
The study protocol was approved by the ethics committee
of the Central African Republic, and written consent for
tuberculin testing and vaccination with BCG was obtained
from the parents or guardians of eligible children.
Sampling
A sample size of 1600 children was estimated for each
region based on an expected TST reactivity rate of 75,
for 3 % precision, a design effect of two, a minimum test
read of 70 and at a 5 % significance level. A list of pri-
mary schools (clusters) and the population size of each
school were obtained from the Ministry of Education. 57
schools (30 in Bangui and 27 in Ombella M’Poko) were
included in the survey after probability proportional
sampling based on the number of children attending each
school. The survey was conducted between February and
April 2011.
Training
A team of six nurses received 4 weeks’ training in using
and reading the TST according to the international
protocol [11] during a pilot survey conducted in four
schools in Bangui in January 2011.
Tuberculin skin testing and data collection
Written consent for children’s participation in the study
was obtained from the parents or legal guardians before
the start of the study. A self-administered questionnaire
was completed by all parents or guardians of children
for age, sex, address, prior BCG vaccination as reported
by parents or guardians or recorded on immunization
cards, household contact with TB and history of chronic
disease and fever. A clinical investigation was performed
to detect any sign of active TB and scars of prior BCG
vaccination. The exclusion criteria were: a history of
chronic disease, symptoms of infectious disease (fever,
cough, runny nose) that might interfere with TST re-
activity, allergic disease and incomplete questionnaire at
the time of screening.
The TST was performed, regardless of BCG scar status,
with two tuberculin units of purified protein derivative
TR23 in Tween, supplied by the Statens Serum Institute
(Copenhagen, Denmark). A dose of 0.1 ml was injected
intradermally into the left forearm. Skin reactions were
read 72 h later, and the transverse diameter of induration
was measured in millimeters with a transparent, flexible
15 mm ruler. Each induration was assessed by one reader;when there was doubt, a reference reader or the principal
investigator did a second reading.
The guidelines of the national TB control programme
state that BCG-vaccinated children with a TST result
≥15 mm and unvaccinated children with a result ≥10 mm
who are household contacts of a TB case and have symp-
toms of TB should be treated with anti-TB drugs. Children
with a TST result ≥15 or 10 mm without a household con-
tact but with symptoms of TB are also investigated. For this
survey, the size of the induration after TST was interpreted
as follows: <5 mm was considered negative, 5–9 mm was
interpreted as doubtful, and ≥10 mm was considered posi-
tive for a recent TB infection [12–14], and these children
were referred to the clinic for investigation for TB.Statistical analysis
Data were double-entered into EpiInfo software version
3.5.3 (Centers for Disease Control and Prevention, USA).
Statistical analysis was conducted with STATA 11.2.
The frequency distribution of induration sizes was
plotted. Age was categorized as 6–9 and 10–12 years,
and TST reaction induration size was categorized at cut-
off points of ≥5 mm, ≥10 mm and ≥15 mm. The results
for each categorical variable (gender, age category, health
region and cut-off points) were presented as frequencies
and proportions. We assessed whether the results dif-
fered according to BCG vaccination and without BCG
scar status, and TST results (cut-off points of ≥5, ≥10
and ≥15 mm) were calculated as odds ratios (ORs) and
their 95 % confidence intervals (CIs). The reaction in-
duration size for each cut-off was considered to be latent
TB infection if the effect of BCG vaccination on tuberculin
reactivity was not statistically significant (OR significantly
different from 1). Proportions were compared in the chi-
squared test. A p v alue <0.05 was considered statistically
significant.
The annual risk for infection was calculated from the
estimated prevalence of infection (P) calculated from the
equation 1–(1–P)1/A, where A is the mean age of the
tested children [15]. Indurations of ≥ 10 mm and ≥15 mm
were selected as cut-off points to estimate the prevalence
of infection and to calculate the annual risk for infection.Results
Of the 3280 children recruited for the survey, we
excluded 174 who were absent at the time of testing, 87
who were absent at the skin test reading and 309 of
unknown BCG status, leaving 2710 (82.6 %) children for
the final analysis, comprising 1469 (54.2 %) in Bangui
and 1241 (45.8 %) in Ombella M’Poko. No suspected
cases of active TB were identified by clinical examin-
ation. Those who completed the TST reading and those
who were absent at time of skin reading did not differ
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TST was 8.5 % (116/1357) in Ombella M’Poko and 3.8 %
(58/1527) in Bangui (p < 0.0001), and the proportions
of children absent at skin reading was 4.4 % in
Ombella M’Poko (57/1298) and 2.0 % in Bangui (30/1499)
(p = 0.0004).
Table 1 shows the distribution of the study population
according to BCG vaccination and BCG scar status by
gender, age and health region. The proportions of non-
vaccinated and vaccinated children did not differ by
gender or age group (p = 0.873 and 0.139, respectively),
but more vaccinated children were found in Bangui
than in Ombella M’Poko (p = 0.014). More children
aged 6–9 years than those aged 10–12 years had a BCG
scar (p = 0.006).
The BCG coverage rate was 83.8 % (2272/2710), and a
BCG scar was observed in 65.9 % of children (95 % CI,
66.5–75.1 %). The plot of tuberculin reaction induration
size showed a bimodal trend at 10 mm and 15 mm
(Fig. 2). There was no reaction to the TST (no TST in-
duration) in 71.7 % (95 % CI, 68.3–75.3 %) of BCG-
vaccinated children and 82.9 % (95 % CI, 74.1–91.4 %)
of non-vaccinated children.
The distribution of positive TST results at each cut-off
value according to BCG scar status is shown in Table 2.
The proportions of children with a TST reaction above
each cut-off value were 23.4 % (95 % CI, 21.6–25.3 %)
at ≥5 mm, 18.4 % (95 CI, 16.8–20.1 %) at ≥10 mm and
8.9 % (95 % CI, 7.8–10.0 %) at ≥ 15 mm. BCG vaccin-
ation status influenced the induration at ≥ 5 mm (OR,
1.8; 95 % CI, 1.4–2.4) and ≥ 10 mm (OR, 1.7; 95 % CI,
1.2–2.3) but not at ≥ 15 mm. There was no evidence
that the proportions above the cut-offs were influenced
by BCG scar status.
The annual infection rate was 2.1 (95 % CI, 1.8–2.4) at
the cut-off point of ≥ 10 mm and 0.9 (95 % CI, 0.8–1.1)
at ≥ 15 mm in Bangui, and 1.8 (95 % CI, 1.5–2.1) and 0.7
(95 % CI, 0.5–0.8) in Ombella M’Poko, respectively. TheTable 1 Distribution of gender, age and geographical area accordin
Characteristics Vaccinated
Yes No P
n (%) n (%)
Gender
Male 1111 (83.7) 216 (16.3) 0.8
Female 1161 (83.9) 222 (16.1)
Age (years)
6–9 979 (85.1) 172 (14.9) 0.1
10–12 1293 (82.9) 266 (17.1)
Health region
Bangui 1255 (85.4) 214 (14.6) 0.0
Ombella M’Poko 1017 (81.9) 224 (18.1)overall rate was estimated to be 1.9 (95 % CI, 1.7–2.2)
for ≥ 10 mm and 0.8 (95 % CI, 0.7–0.9) for ≥ 15 mm.
Discussion
The proportions of children who had a TST reaction
above the ≥ 10 mm and ≥ 15 mm cut-offs were 18.4 and
8.9 %, respectively, and the annual rate was 0.8 % above
the ≥15 mm cut-off. A previous study conducted in
Bangui in 1988 reported a prevalence of the TB infection
of 7.9 ± 1.7 % and annual infection rate of 1.09 %. How-
ever, this previous study fixed the limit of positivity at
14 mm based to the bimodal distribution of the diameters
TST induration diameter. Nevertheless, this profile of
findings reflects that latent TB infection did not vary
significantly during the period between these two studies.
BCG vaccination status had no effect on tuberculin
reactivity (OR not significantly different from 1), which
justifies use of the method for estimating prevalence and
infection rate regardless of vaccination status. Many
studies in other countries have demonstrated the useful-
ness of the TST for screening for TB infection regardless
of BCG status, and there is growing consensus that the
effect of neonatal vaccination with BCG wanes after
about 5 years [16–18]. There is persistent reluctance,
however, to agree that BCG vaccination induces sensitivity
to tuberculin that might interfere with interpretation of
TST results [19–21]. In our survey, the effect of having a
BCG scar on TST reactivity was not statistically significant
at the cut-off of ≥10 mm, and the proportion of BCG-
vaccinated children who were TST negative was high. This
finding is consistent with those of other studies [13, 16, 22].
The finding that the distribution profile of TST in-
duration had a bimodal distribution at 10 and 15 mm
indicates circulation of non-typical mycobacteria (NTM).
A distribution with a higher proportion of lower reaction
sizes is expected when cross-reaction with NTM is
present [13]. Unfortunately, data on the prevalence of
NTM in the Central African Republic is not available. Ing to BCG vaccination and BCG scar status
Vaccinated
Without BCG scar BCG scar P
n (%) n (%)
73 371 (33.4) 740 (66.6) 0.508
403 (34.1) 758 (65.9)
39 303 (30.9) 676 (69.1) 0.006
471 (36.4) 822 (63.6)
14 439 (35.0) 816 (65.0) 0.308
335 (32.9) 682 (67.1)
Fig. 2 Distribution of TST induration (≥1 mm)
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threshold value of 10 mm overestimates the prevalence
of M. tuberculosis infection because of cross-sensitivity
[23]. Hence, the induration threshold of ≥15 mm may be
suitable for estimating the prevalence of infection and for
calculating the annual risk for infection in the country.
This study has various limitations. The main one is
that schoolchildren may not be representative of all
children of school age in the country. Although accurate
information on school attendance in the Central African
Republic is not available, it is assumed to be low in rural
areas (i.e. Ombella M’Poko). Children who are not at
school are at higher risk for TB, because they often live
in families of lower socio-economic status. Another
limitation is that TST has low sensitivity in immuno-
compromised patients and in those with nutritional de-
ficiency. The children in our survey were not tested for
HIV infection. A study conducted between April 1998
and June 2000 reported that TB and HIV co-infection
among children hospitalized in Bangui was 25.7 %
(95 % CI, 20.7–31.2 %) [24]. The burden of TB in children
is expected to be higher in high-incidence countries
affected by the HIV epidemic [25]. The participants of
this study were born between 1999 and 2005, while a
study conducted in antenatal clinics in 2002 found a
prevalence of HIV infection of 15 % among pregnant
women [26]. As the transmission mother-to-childrenTable 2 Positive tuberculin skin test by induration size cut-off accor
Cut-off
point (mm)
All Without BCG scar
n (%) 95 % CI n (%) 95
5 634 (23.4) [21.6–25.3] 182 (23.5) [20
10 499 (18.4) [16.8–20.1] 151 (19.5) [16
15 240 (8.9) [7.8–10.0] 84 (10.8) [8.7
aCrude odds ratioprogram was implemented in 2004, we expected that
the majority of children were at high risk of HIV trans-
mission (approximately 30 %). However, it is considered
that the mortality observed among infected infants is
very high [27, 28], and it is likely that very few these
children might be HIV-infected in this study.
We did not study nutritional status; however, as there
are poor socioeconomic conditions in the country, nutri-
tional deficiency may have resulted in an underestimate of
the TST reaction in this study. Better methods for detecting
M. tuberculosis-specific antigen are emerging, including
interferon gamma-release assays [29–31], even though
negative results have been found with these assays with
TST positive results [32], and there are significant differ-
ences in the performance of the two assays at ≥10 mm
and ≥15 mm cut-offs [33]. Another limitation of this study
is that information on BCG vaccination was based on re-
call by parents and guardians, who may not give accurate
information on the BCG status of their children.
Conclusion
This survey showed that a relatively high proportion of
schoolchildren had negative tuberculin reactivity, irre-
spective of their BCG status. We provide updated data
on the prevalence of TB infection and the annual risk
for this infection. More studies are needed to understand
the factors involved in the low tuberculin reactivity ofding to BCG scar status
BCG scar BCG effect
% CI n (%) 95 % CI ORa 95 % CI
.2–27.2] 384 (25.6) [23.1–28.3] 1.1 [0.9–1.4]
.5–22.9] 293 (19.6) [17.4–21.9] 1.0 [0.8–1–2]
–13.4] 121 (8.1) [6.7–9.6] 0.7 [0.5–1.0]
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It would be valuable to confirm these results in other parts
of the Central African Republic before the conclusions can
be generalized.
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